Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 304,633 clinical trials worldwide
Search
Showing 82701-82750 of 304,633 trials
Active filters:
Status: Completed
Clinical Trials (304,633)
NCT03899909
A Study to Evaluate the Effects of a Single and Multiple Oral Doses of GLPG3121 in Adult, Healthy, Male Subjects
PHASE1
Completed
31 participants
Started: Mar 29, 2019 · Completed: Jun 3, 2019
1 condition
1 sponsor
1 location
NCT05127668
Efficacy of AirGLovE in Difficult Venous Access
NA
Completed
34 participants
Started: Mar 29, 2019 · Completed: Apr 16, 2019
1 condition
1 sponsor
1 location
NCT03831893
Metabolic Effects of Nopal in Healthy Humans
NA
Completed
21 participants
Started: Mar 29, 2019 · Completed: Aug 13, 2019
1 condition
1 sponsor
1 location
NCT03895606
Prediction of Kidney Injury After Hyperthermic Intraperitoneal Chemotherapy (HIPEC)* With Machine Learning
N/A
Completed
57 participants
Started: Mar 29, 2019 · Completed: Mar 18, 2020
2 conditions
1 sponsor
1 location
NCT04828733
One Anastomosis Gastric Bypass With Excluded Stomach Fundoplication: FundoRing vs Nissen vs OAGB Without Fundoplication
NA
Completed
150 participants
Started: Mar 29, 2019 · Completed: May 10, 2024
2 conditions
1 sponsor
1 location
NCT03857178
SABINA INTERNATIONAL
N/A
Completed
8,617 participants
Started: Mar 29, 2019 · Completed: May 6, 2020
1 condition
1 sponsor
1 location
NCT03743766
Nivolumab, BMS-936558 in Combination with Relatlimab, BMS-986016 in Patients with Metastatic Melanoma Naïve to Prior Immunotherapy in the Metastatic Setting
PHASE2
Completed
42 participants
Started: Mar 29, 2019 · Completed: Jul 3, 2024
1 condition
2 sponsors
1 location
NCT03819400
Evaluation of Kidney Graft's Fibrosis With Real Time Shear-wave Elastography
N/A
Completed
45 participants
Started: Mar 29, 2019 · Completed: May 16, 2022
1 condition
1 sponsor
1 location
NCT03822208
First in Human Study for Safety and Tolerability of AL003.
PHASE1
Completed
54 participants
Started: Mar 29, 2019 · Completed: May 6, 2021
2 conditions
1 sponsor
6 locations
NCT03991143
Efficacy, Safety and Tolerability of ATH3G10 in Patients With ST-elevation Myocardial Infarction
PHASE2
Completed
82 participants
Started: Mar 29, 2019 · Completed: Apr 19, 2021
1 condition
1 sponsor
1 location
NCT03905850
A Study to Compare the Uptake Into the Blood of Two Strengths of Somapacitan After Injection Under the Skin in Healthy Subjects
PHASE1
Completed
33 participants
Started: Mar 29, 2019 · Completed: Jul 15, 2019
2 conditions
1 sponsor
1 location
NCT03897660
MaxSimil and Vitamin K2: Determining Their Bioavailability
NA
Completed
22 participants
Started: Mar 29, 2019 · Completed: Mar 31, 2020
1 condition
2 sponsors
1 location
NCT03881267
SkinTE® in the Treatment of Venous Leg Wounds
NA
Completed
29 participants
Started: Mar 29, 2019 · Completed: Mar 23, 2021
3 conditions
2 sponsors
2 locations
NCT03820596
Sintilimab in Combination With Chidamide in Refractory and Relapsed ENKTCL
PHASE1/PHASE2
Completed
40 participants
Started: Mar 29, 2019 · Completed: Nov 30, 2021
1 condition
1 sponsor
4 locations
NCT04762095
The Effect of Mindfulness Stress Reduction Program on Menopausal Complaints and Quality of Life
NA
Completed
113 participants
Started: Mar 29, 2019 · Completed: Jan 20, 2021
1 condition
1 sponsor
1 location
NCT03763877
A Study of the Efficacy and Safety of PXL770 Versus Placebo After 12 Weeks of Treatment in Patients With NAFLD
PHASE2
Completed
121 participants
Started: Mar 29, 2019 · Completed: Aug 10, 2020
1 condition
1 sponsor
15 locations
NCT03878810
Exergaming in Persons With Multiple Sclerosis With Restless Legs Syndrome
NA
Completed
65 participants
Started: Mar 29, 2019 · Completed: Dec 15, 2021
1 condition
1 sponsor
1 location
NCT03896204
Effect of Telephone-supported Joint Protection Technique Training
NA
Completed
50 participants
Started: Mar 29, 2019 · Completed: May 29, 2019
2 conditions
1 sponsor
1 location
NCT04192214
The Persistence of Autoantibody Neutralisation by BC 007 in Patients With Chronic HFrEF and Autoantibodies Against the Beta1-Adrenergic Receptor
PHASE2
Completed
30 participants
Started: Mar 29, 2019 · Completed: Dec 6, 2022
3 conditions
1 sponsor
3 locations
NCT03917329
Evaluation of an ACT and PBS Group for Parents and Education Staff
NA
Completed
37 participants
Started: Mar 29, 2019 · Completed: Dec 16, 2019
5 conditions
2 sponsors
2 locations
NCT04118374
A Study to Determine Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes
NA
Completed
12 participants
Started: Mar 29, 2019 · Completed: Jun 21, 2024
1 condition
1 sponsor
1 location
NCT03897088
Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasis
PHASE3
Completed
231 participants
Started: Mar 29, 2019 · Completed: Feb 17, 2022
1 condition
1 sponsor
25 locations
NCT03896581
A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
PHASE3
Completed
400 participants
Started: Mar 28, 2019 · Completed: Feb 14, 2022
1 condition
1 sponsor
92 locations
NCT03864185
The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies
PHASE2
Completed
25 participants
Started: Mar 28, 2019 · Completed: May 27, 2021
1 condition
3 sponsors
4 locations
NCT03947398
The BLIMP Balloon in Coronary Interventions
NA
Completed
128 participants
Started: Mar 28, 2019 · Completed: Mar 28, 2021
2 conditions
11 sponsors
2 locations
NCT03914833
Impact of Sports-related Concussions on the Attention and Executive Skills of Adolescents and Young Adults: Links With Subjective Symptoms and Recovery
N/A
Completed
72 participants
Started: Mar 28, 2019 · Completed: Mar 10, 2020
1 condition
1 sponsor
1 location
NCT03915379
A Study of JNJ-67571244 in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
PHASE1
Completed
68 participants
Started: Mar 28, 2019 · Completed: Mar 28, 2022
2 conditions
1 sponsor
17 locations
NCT03803345
The Association of Maternal Night-Eating Pattern With Glucose Tolerance During Pregnancy
N/A
Completed
300 participants
Started: Mar 28, 2019 · Completed: Mar 11, 2022
1 condition
4 sponsors
1 location
NCT03930342
Native-Changing High-risk Alcohol Use and Increasing Contraception Effectiveness Study
NA
Completed
404 participants
Started: Mar 28, 2019 · Completed: Oct 30, 2023
3 conditions
5 sponsors
2 locations
NCT04111354
Early Mobilization After Pacemaker Implantation.
NA
Completed
200 participants
Started: Mar 28, 2019 · Completed: Aug 31, 2024
2 conditions
1 sponsor
1 location
NCT03639935
Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum Therapy
PHASE2
Completed
32 participants
Started: Mar 28, 2019 · Completed: Apr 30, 2024
1 condition
3 sponsors
3 locations
NCT03797599
Study Examining the Effects of Mindfulness and Similar Audio-guided Exercises.
NA
Completed
71 participants
Started: Mar 28, 2019 · Completed: Dec 5, 2019
2 conditions
1 sponsor
1 location
NCT04386655
Brain Injury Coping Skills - Telemedicine: Phase II
NA
Completed
49 participants
Started: Mar 28, 2019 · Completed: Aug 1, 2020
3 conditions
1 sponsor
1 location
NCT03810014
Malaria Diagnostic Testing and Conditional Subsidies to Target ACTs in the Retail Sector: the TESTsmART Trial AIM 1
NA
Completed
842 participants
Started: Mar 28, 2019 · Completed: Oct 31, 2019
2 conditions
4 sponsors
1 location
NCT03786198
Activity Program During Aromatase Inhibitor Therapy
NA
Completed
375 participants
Started: Mar 28, 2019 · Completed: Jun 8, 2023
1 condition
1 sponsor
32 locations
NCT03896022
Auriculotherapy - Pain Management of Aspiration Abortion
NA
Completed
177 participants
Started: Mar 28, 2019 · Completed: Dec 12, 2019
1 condition
2 sponsors
1 location
NCT03965871
Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Bipolar Depression
PHASE2
Completed
88 participants
Started: Mar 28, 2019 · Completed: Feb 19, 2021
1 condition
2 sponsors
12 locations
NCT02905188
Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR)
PHASE1
Completed
9 participants
Started: Mar 28, 2019 · Completed: Jan 6, 2023
1 condition
4 sponsors
1 location
NCT03922217
e-Mindfulness for Depression in Older Adults
NA
Completed
31 participants
Started: Mar 28, 2019 · Completed: Dec 5, 2023
2 conditions
1 sponsor
1 location
NCT03763591
Psychological Skills Group for Youth of Refugee and Immigrant Backgrounds
NA
Completed
13 participants
Started: Mar 28, 2019 · Completed: Feb 9, 2023
2 conditions
1 sponsor
1 location
NCT04159727
Gut Microbiota Dysbiosis and Translocation During IBD and Parkinson
NA
Completed
15 participants
Started: Mar 28, 2019 · Completed: Feb 13, 2020
2 conditions
1 sponsor
1 location
NCT03774875
A Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Adults With Manifestations of Plaque Psoriasis and Impaired Quality of Life
PHASE4
Completed
277 participants
Started: Mar 28, 2019 · Completed: Nov 3, 2021
1 condition
1 sponsor
72 locations
NCT05294432
Validation of the Pain Relief Measure
N/A
Completed
97 participants
Started: Mar 28, 2019 · Completed: Oct 21, 2024
1 condition
1 sponsor
1 location
NCT05299619
Tixel Treatment for Dry Eye Symptoms
NA
Completed
40 participants
Started: Mar 28, 2019 · Completed: Mar 28, 2022
2 conditions
1 sponsor
1 location
NCT03916445
Resilience and Quality of Life in Patients With Gynaecological Carcinomas and Chronic Gynaecological Diseases
N/A
Completed
132 participants
Started: Mar 28, 2019 · Completed: Apr 26, 2019
2 conditions
1 sponsor
1 location
NCT03934983
Evaluation of the Clinical Performance of the Quantra System With the QStat Cartridge in Trauma
N/A
Completed
30 participants
Started: Mar 28, 2019 · Completed: Jan 31, 2020
2 conditions
1 sponsor
1 location
NCT03854526
Evaluation of Dental Coronal Restorations
N/A
Completed
863 participants
Started: Mar 28, 2019 · Completed: Dec 23, 2021
1 condition
1 sponsor
61 locations
NCT04171362
The Effect of Connective Tissue Massage in Patients With Migraine
NA
Completed
16 participants
Started: Mar 28, 2019 · Completed: Dec 20, 2019
4 conditions
1 sponsor
1 location
NCT03771963
Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) at the End of Shelf Life in Healthy Adults
PHASE3
Completed
200 participants
Started: Mar 28, 2019 · Completed: Mar 13, 2020
1 condition
1 sponsor
2 locations
NCT03873870
68Ga-DOTATATE PET for Management of Neuroendocrine Tumors
NA
Completed
1,916 participants
Started: Mar 28, 2019 · Completed: Apr 30, 2023
1 condition
1 sponsor
1 location
Previous
1
More pages
1652
1653
1654
1655
1656
1657
1658
More pages
6093
Next